Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD.

Tucked away in the countryside of northern Vietnam is this relaxed and peaceful village with beautiful landscapes… If you’re heading to Vietnam, Ninh Binh is a gem that absolutely needs to be on your ...